Edmond de Rothschild Holding’s Phio Pharmaceuticals PHIO Stock Holding History

Edmond de Rothschild Holding’s Portfolio PHIO Stock Details PHIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-116	Closed	-$22K	–	636
2020 Q1	$22K	Buy	+116	New	+$71.5K	﹤0.01%	504
2019 Q1	–	Sell	-2	Closed	-$4K	–	672
2018 Q4	$4K	Hold	2	–	–	﹤0.01%	655
2018 Q3	$13K	Buy	2 +1	+100%	+$9.41K	﹤0.01%	695
2018 Q2	$9K	Buy	+1	New	+$14.8K	﹤0.01%	712

Other funds holding PHIO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

Edmond de Rothschild Holding's PHIO Position: Q2 2020 in Review

Edmond de Rothschild Holding sold out of Phio Pharmaceuticals (PHIO) in Q2 2020, closing a stake of 116 shares — an estimated $22K sold.

Edmond de Rothschild Holding first reported a position in PHIO in Q2 2018 and held it in 4 quarters. The position peaked at $22K in Q1 2020. 6 funds tracked by Wall St. Rank hold PHIO as of Q2 2020.

Edmond de Rothschild Holding reported no remaining Phio Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
Edmond de Rothschild Holding sold 116 Phio Pharmaceuticals shares in Q2 2020, an estimated $22K.
Edmond de Rothschild Holding first reported a position in Phio Pharmaceuticals in Q2 2018 and held it in 4 quarters.
Edmond de Rothschild Holding's Phio Pharmaceuticals position peaked at $22K in Q1 2020.
6 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q2 2020.

Based on Edmond de Rothschild Holding's 13F filing for Q2 2020, filed 7 Aug 2020.